Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cardioprotective Effect of Melatonin Versus Vitamin D in Breast Cancer Patients Receiving Doxorubicin
NCT07349459Completed
- Sponsor
- Tanta University
- Start
- Apr 2025
- Primary completion
- May 2026
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Trial of melatonin and vitamin d in Cardiotoxicity, sponsored by Tanta University. Primary endpoint: Decreasing incidence and severity of cardiotoxicity at 12 weeks. Started Apr 2025; status: completed.
02
Drugs
melatoninvitamin d
03
Conditions
Cardiotoxicity
Beyond the preview
Go deeper on NCT07349459.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07349459.